##  [Novartis in Society Integrated Report ](/us-en/esg/corporate-responsibility/novartis-society-integrated-report "Novartis in Society Integrated Report ") 

  ![Scientist in Cambridge, MA](/us-en/sites/novartis_us/files/styles/crop_freeform/public/2025-02/scientist-in-cambridge.png.webp?itok=CR0mLRvZ "Scientist in Cambridge, MA")

 

Novartis is an innovative medicines company engaged in the research, development and manufacturing of a broad range of innovative medicines. In 2024, our medicines reached 296 million patients around the world. As a leader in life sciences, we are pursuing innovative approaches to making medicines more affordable and accessible and strengthening our partnerships with communities and society.   
  
Our 2024 Novartis in Society Integrated Report highlights some of the many ways we are contributing to this. Together, we are driving meaningful change to accelerate innovation, expand patient access and create a more inclusive and sustainable healthcare system for all.



 



 ![Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida](/us-en/sites/novartis_us/files/styles/cta_image/public/2025-02/portrait-of-kate-kostelyk-and-her-labrador.jpeg.webp?itok=6Gb8Pqsl "Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida") 

 

##  Novartis in Society Integrated Report 2024 

Read more about our performance against our business, environmental, social and governance (ESG) priorities.

 

 [Download the Integrated Report (PDF 5.0 MB)](https://www.novartis.com/sites/novartis_com/files/novartis-integrated-report-2024.pdf "Download the Integrated Report (PDF 5.0 MB)") 



 

 



 





 

 [Novartis US Foundation ](/us-en/esg/corporate-responsibility/novartis-us-foundation "Novartis US Foundation ") 



 [People and communities ](/us-en/esg/corporate-responsibility/people-and-communities "People and communities ") 



 [Beacon of hope ](/us-en/esg/corporate-responsibility/beacon-hope "Beacon of hope ") 



 

 









**Usage Rights & Restrictions**

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.